Provide for fees and assessments for participation and use of the prescription drug monitoring program and the designated health information exchange

Nebraska's LB 210 establishes fees for healthcare providers and organizations to access the state's prescription drug monitoring program (PDMP) and health information exchange. It requires pharmacies to report all prescription drug data daily (except for emergency or immunization-related prescriptions) and mandates that doctors, pharmacies, and health information exchanges pay access fees to view this data. The bill also clarifies that patient data remains confidential, with limited exceptions for authorized providers and health exchanges. These fee structures aim to fund the system while maintaining data privacy standards under federal law.